Elevar Therapeutics, Inc design mark 50114932
"Design mark 50114932" is a figurative mark owned by Elevar Therapeutics, Inc., filed at the USPTO on September 17, 2026. It is under examination and covers class 5 (Pharmaceuticals).
- Status
- Under examination
- Since September 17, 2026
- Filed
- September 17, 2026
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 50114932
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Figurative mark
- 1 class
Who owns Elevar Therapeutics, Inc design mark 50114932
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Elevar Therapeutics, Inc.
Fort Lee, United States
Representative
Cynthia Johnson Walden
Fish & Richardson P.C.
What the mark covers
The products and services Elevar Therapeutics, Inc design mark 50114932 is filed for, grouped by Nice class.
Pharmaceutical products for the treatment of cancer
What has happened so far
Steps recorded by the USPTO, newest first.
- Application filing receipt mailed
- New application entered
About Elevar Therapeutics, Inc design mark 50114932
Who owns the trademark "Design mark 50114932"?
The USPTO trademark "Design mark 50114932" (application 50114932) is owned by Elevar Therapeutics, Inc.
What is the status of "Design mark 50114932"?
Its status at the USPTO is: under examination.
Get this data via the API
Everything on this page comes from the Signa API. Pull Elevar Therapeutics, Inc design mark 50114932 and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_01a0b4a2-6487-724e-96e1-9b6e20db8944
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_01a0b4a2-6487-724e-96e1-9b6e20db8944",
"object": "trademark",
"mark_text": "[Design Mark]",
"status": {
"primary": "pending",
"stage": "examining"
},
"office_code": "US",
"application_number": "50114932",
"filing_date": "2026-09-17",
"nice_classes": [
5
],
"owners": [
{
"name": "Elevar Therapeutics, Inc.",
"entity_id": "ent_019ebbf1-741f-77fb-b3fe-d1b27507b039"
}
]
}